Cargando…

Megadose CD34+ Hemopoietic Stem Cell Transplantation for Patients with High Risk Acute Myeloid Leukemia Who Have No HLA Matched Donor: A Pilot Study of a Full Haplotype Mismatch Transplantation

BACKGROUND : Haploidentical transplantation has become a popular modality of treatment for acute myeloid leukemia (AML) patients lacking donors with matching HLA. We attempted to assess the success rate and ramifications of full haplotype mismatch transplantation. METHODS : Four patients received st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Hee-Je, Min, Woo-Sung, Park, Yoon-Hee, Kim, Yoo-Jin, Seok-Lee, Kim, Dong-Wook, Lee, Jong-Wook, Kim, Chun-Choo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Association of Internal Medicine 2004
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4531581/ https://www.ncbi.nlm.nih.gov/pubmed/15683113 http://dx.doi.org/10.3904/kjim.2004.19.4.243

Ejemplares similares

HLA Haplotype Mismatch Transplants and Posttransplant Cyclophosphamide
por: Bacigalupo, Andrea, et al.
Publicado: (2016)

HLA-mismatched donor and high ferritin level showed poor clinical outcomes after allogeneic hematopoietic cell transplantation in patients with advanced myelofibrosis
por: Yoon, Jae-Ho, et al.
Publicado: (2020)

CTLA-4 polymorphisms and haplotype correlate with survival in ALL after allogeneic stem cell transplantation from related HLA-haplotype-mismatched donor
por: Qin, X.-Y., et al.
Publicado: (2016)

Donor Selection for Allogenic Hemopoietic Stem Cell Transplantation: Clinical and Ethical Considerations
por: Riezzo, Irene, et al.
Publicado: (2017)

Effects of Mixed Chimerism and Immune Modulation on GVHD, Disease Recurrence and Survival after HLA-identical Marrow Transplantation for Hematologic Malignancies
por: Park, Soo-Jeong, et al.
Publicado: (2000)

Hematopoietic stem cell transplantation for thalassemia major using HLA fully-matched and mismatched donor grafts
por: Huang, Chuwen, et al.
Publicado: (2021)

Decision analysis for donor selection in stem cell transplantation—HLA-8/8 allele-matched unrelated donor vs HLA-1 AG mismatched related donor
por: Kanda, J, et al.
Publicado: (2014)

The impact of HLA matching on unrelated donor hematopoietic stem cell transplantation in Korean children
por: Park, Meerim, et al.
Publicado: (2011)

The clinical impact of donor against recipient HLA one way mismatch on the occurrence of graft versus host disease in liver transplantation
por: Kim, Sang Jin, et al.
Publicado: (2022)

Efficacy of Living Donor Liver Transplantation in Patients with Methylmalonic Acidemia
por: Jang, Jae Guk, et al.
Publicado: (2021)

Characteristics and Clinical Significance of De Novo Donor-Specific Anti-HLA Antibodies after Kidney Transplantation
por: Jung, Hee-Yeon, et al.
Publicado: (2018)

Megadose Methylprednisolone (MDMP) for Hemangiomatosis
por: Özsoylu, Şinasi
Publicado: (2012)

Megadose Methylprednisolone (MDMP) for Hemangiomatosis
por: Küpeli, Serhan, et al.
Publicado: (2012)

Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021
por: Bacigalupo, Andrea, et al.
Publicado: (2021)

Daratumumab for donor-specific anti-HLA antibody desensitization in a case of HLA-mismatched allogeneic stem cell transplantation
por: Ibrahim, Uroosa, et al.
Publicado: (2023)

Early hospital readmissions after ABO- or HLA- incompatible living donor kidney transplantation
por: Lee, Juhan, et al.
Publicado: (2019)

Author Correction: The clinical impact of donor against recipient HLA one way mismatch on the occurrence of graft versus host disease in liver transplantation
por: Kim, Sang Jin, et al.
Publicado: (2022)

Transplantation of highly purified peripheral blood CD34(+) cells from HLA-mismatched parental donors in 14 children: evaluation of early monitoring of engraftment
por: Peters, C, et al.
Publicado: (1999)

Liver Transplantation for Metabolic Liver Disease: Experience at a Living Donor Dominant Liver Transplantation Center
por: Kim, Jun Suk, et al.
Publicado: (2015)

The Presence of Anti-HLA Antibodies before and after Allogeneic Hematopoietic Stem Cells Transplantation from HLA-Mismatched Unrelated Donors
por: Koclega, Anna, et al.
Publicado: (2012)

Impact of Previously Unrecognized HLA Mismatches Using Ultrahigh Resolution Typing in Unrelated Donor Hematopoietic Cell Transplantation
por: Mayor, Neema P., et al.
Publicado: (2021)

Clinical implications of HLA locus mismatching in unrelated donor hematopoietic cell transplantation: a meta-analysis
por: Tie, Ruxiu, et al.
Publicado: (2017)

Donor/Recipient HLA Molecular Mismatch Scores Predict Primary Humoral and Cellular Alloimmunity in Kidney Transplantation
por: Meneghini, Maria, et al.
Publicado: (2021)

Iron Toxicity and Hemopoietic Cell Transplantation: Time to Change the Paradigm
por: Pilo, Federica, et al.
Publicado: (2019)

Risk Due to ABO Incompatibility and Donor-Recipient Weight Mismatch in Living Donor Kidney Transplantation: A National Cohort Study
por: Lee, Jun Young, et al.
Publicado: (2021)

Case report: Rare persistent complete donor chimerism and GVHD following micro-transplantation from HLA haplotype homozygous donors
por: Liu, Lingling, et al.
Publicado: (2022)

The Association Between Broad Antigen HLA Mismatches, Eplet HLA Mismatches and Acute Rejection After Kidney Transplantation
por: Do Nguyen, Hung Thanh, et al.
Publicado: (2016)

Clinical Characteristics and Outcomes of Posttransplant Lymphoproliferative Disorders Following Allogeneic Hematopoietic Stem Cell Transplantation in Korea
por: Park, Sun Hee, et al.
Publicado: (2006)

Fecal microbiota transplantation for steroid-refractory gastrointestinal graft-versus-host disease
por: Kim, Hyun Min, et al.
Publicado: (2023)

Effect of the similarity of gut microbiota composition between donor and recipient on graft function after living donor kidney transplantation
por: Kim, Ji Eun, et al.
Publicado: (2020)

The Risk of Transplant Failure With HLA Mismatch in First Adult Kidney Allografts 2: Living Donors, Summary, Guide
por: Williams, Robert C., et al.
Publicado: (2017)

Improved GRFS after posttransplant cyclophosphamide-based vs ATG-based HLA-mismatched unrelated donor transplant
por: Jimenez Jimenez, Antonio, et al.
Publicado: (2022)

ALTERNATIVE DONORS EXTEND TRANSPLANTATION FOR PATIENTS WITH LYMPHOMA WHO LACK AN HLA MATCHED DONOR
por: Bachanova, Veronika, et al.
Publicado: (2014)

Clinical Relevance of Pretransplant HLA Class II Donor-specific Antibodies in Renal Transplantation Patients with Negative T-cell Cytotoxicity Crossmatches
por: Song, Eun Young, et al.
Publicado: (2012)

Megadose (90)Y-ibritumomab tiuxetan prior to allogeneic transplantation is effective for aggressive large B-cell lymphoma
por: Chow, Victor A., et al.
Publicado: (2021)

A Case Report of the Second de Novo Acute Myeloid Leukemia (AML) Following Allogeneic Stem Cell Transplantation in a Patient with the First AML
por: Cho, Byung-Sik, et al.
Publicado: (2010)

Comparison of Clinical Outcomes Between Preemptive Transplant and Transplant After a Short Period of Dialysis in Living-Donor Kidney Transplantation: A Propensity-Score-Based Analysis
por: Kim, Hye Yeon, et al.
Publicado: (2019)

Donor-Recipient Size Mismatch in Paediatric Renal Transplantation
por: Donati-Bourne, J., et al.
Publicado: (2014)

Megadose Methylprednisolone (MDMP) For Granulocytic Sarcoma (GS)
por: ÖZSOYLU, Şinasi
Publicado: (2013)

Post-transplantation Cyclophosphamide: From HLA-Haploidentical to Matched-Related and Matched-Unrelated Donor Blood and Marrow Transplantation
por: Williams, Louis, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lj5rkd6e661ha27pfr09vnaokl